New Notices
- New Notice of Intent to Revise: Inhalation Drug Product Monographs: Removal of Performance Tests (posted 25–Jun–2021) | En español
- Updated General Announcement: New Inhalation Product Monographs: Proposed Approach for Performance Tests Employing Non-Standard Apparatus (posted 25–Jun–2021)
- New General Announcement: Bacterial Endotoxin Test (BET): A USP Comparability Study of Recombinant Reagents (Recombinant Factor C and Recombinant Cascade) to Lysate Reagents (LAL) (posted 25–Jun–2021)
- Update Notice of Intent to Revise: Sucrose (posted 18–Jun–2021)
- New General Announcement: Bacterial Endotoxins Test (BET): USP Requests Additional Data for the Comparability of Recombinant Reagents to Compendial Reagents (posted 11–Jun–2021)
- List of Monographs Appearing in Redesigned Format as of USP–NF 2021, Issue 3 (posted 01–Jun–2021)
- New Pending Notice of Intent to Revise: Lacosamide (posted 28–May–2021)
- New Pending Notice of Intent to Revise: Metformin Hydrochloride Extended-Release Tablets (posted 28–May–2021)
- New Pending Notice of Intent to Revise: Methylprednisolone Sodium Succinate for Injection (posted 28–May–2021)
- New Notice of Intent to Revise: Ipratropium Bromide Inhalation Solution (posted 28–May–2021)
- New Notice of Intent to Revise: Orlistat (posted 28–May–2021)
- New Notice of Intent to Revise: Orlistat Capsules (posted 28–May–2021)
- New Notice of Intent to Revise: Azeotropic Isopropyl Alcohol (posted 30–Apr–2021)
- New Notice of Intent to Revise: Baclofen Injection (posted 30–Apr–2021)
- New Notice of Intent to Revise: Benztropine Mesylate (posted 30–Apr–2021)
- New Notice of Intent to Revise: Copovidone (posted 30–Apr–2021)
- New Notice of Intent to Revise: Isopropyl Alcohol (posted 30–Apr–2021)
- New General Chapter Prospectus: <901> Detection of Asbestos in Pharmaceutical Talc (posted 30–Apr–2021)
- New General Chapter Prospectus: <1901>Theory and Practice of Asbestos Detection in Pharmaceutical Talc (posted 30–Apr–2021)
- New Notice of Intent to Revise: Albuterol Inhalation Solution (posted 16–Apr–2021)
- New Notice of Intent to Revise: Monographs Affected by Revision to <941> Characterization of Crystalline and Partially Crystalline Solids by X-Ray Powder Diffraction (XRPD) (posted 06–Apr–2021)
- Updated Notice of Intent to Revise: Sucrose (posted 26–Feb–2021; updated 02–Apr–2021)